Zobrazeno 1 - 10
of 17
pro vyhledávání: '"M J, Mehlman"'
Autor:
M J, Mehlman
Publikováno v:
Wake Forest law review. 34(3)
Genetic enhancement technologies present difficult and novel regulatory issues, including the problem of measuring and comparing risks and benefits and dealing with the impact of these technologies on social values. This Article describes and evaluat
Autor:
M J, Mehlman
Publikováno v:
Iowa law review. 85(2)
Autor:
M J, Mehlman
Publikováno v:
Health matrix (Cleveland, Ohio : 1991). 11(1)
Autor:
M J, Mehlman
Publikováno v:
Frontiers of health services management. 17(3)
The growing use of genetic testing for diagnostic and predictive purposes, and for the purpose of selecting therapeutic regimens with better risk-benefit ratios for patients, raises numerous legal and ethical challenges. Researchers and institutional
Autor:
M J, Mehlman, E D, Kodish, P, Whitehouse, A B, Zinn, S, Sollitto, J, Berger, E J, Chiao, M S, Dosick, S B, Cassidy
Publikováno v:
American journal of human genetics. 58(2)
Concerns are mounting about the risks of genetic discrimination resulting from the release of predictive and presymptomatic genetic test results to employers, insurers, and others. The ability to keep this information confidential is questionable, pa
Autor:
M J, Mehlman
Publikováno v:
American journal of lawmedicine. 20(1-2)
Autor:
M J, Mehlman
Publikováno v:
Specialty law digest. Health care law. (176)
Autor:
M J, Mehlman
Publikováno v:
Health matrix (Cleveland, Ohio : 1991). 1(2)
Autor:
M J, Mehlman
Publikováno v:
Health matrix (Cleveland, Ohio : 1991). 1(1)
Autor:
M J, Mehlman, K A, Visocan
Publikováno v:
Houston law review. 29(4)